Printer Friendly

NATIONAL PHARMACEUTICAL COUNCIL/RESEARCH AMERICA SEMINAR

 NATIONAL PHARMACEUTICAL COUNCIL/RESEARCH AMERICA SEMINAR
 The National Pharmaceutical Council and Research! America are


sponsoring a press briefing on the pharmaceutical industry's progress in the research and development of medicines to treat women. Future directions for the treatment of diseases including osteoporosis will be discussed. Additionally, scientists investigating new alternatives for contraception and dealing with menopause will be featured.
 Please hold this date for a seminar that will give you a look into the future of these exciting and promising areas.
 TIME: Wednesday, April 8, 9 a.m., (Please note time change)
 PLACE: The Essex House, 160 Central Park South
 (between 6th & 7th avenues), New York City
 Presentations will include:
 -- The effectiveness of a new delivery system in treating osteoporosis to be covered by Donnica Moore, M.D., associate director, Sandoz Medical Education Center, Sandoz Pharmaceutical Corporation.
 -- Innovative approaches for contraception, discussed by Audrey Phillips, Ph.D., research manager, contraceptive research, R.W. Johnson Pharmaceutical Research Institute, Research Arm for Ortho Pharmaceutical Corporation.
 -- Current research in hormone therapy, including contraception, perimenopause and hormone replacement therapy, discussed by Randall Whitcomb, M.D., associate director, clinical research, endocrine for the Parke-Davis Pharmaceutical Research Division of Warner-Lambert Company.
 Continental breakfast will be served. Please call to reserve your place.
 CONTACT: Chris Malter, 212-715-1613, or Nancy Caravetta, 212-715-1629, both of National Pharmaceutical Council, Inc.
 -0- 4/2/92


CO: National Pharmaceutical Council; Research!America ST: New York IN: MTC SU:

AH-KW -- NY006 -- 4209 04/02/92 09:00 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 2, 1992
Words:245
Previous Article:SOCIETY OF CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (SCVIR) ANNUAL MEETING
Next Article:SCHWAB ANNOUNCES NO-ANNUAL FEE INDIVIDUAL RETIREMENT ACCOUNT AND LIFETIME GUARANTEE FOR QUALIFYING INVESTORS
Topics:


Related Articles
PFIZER ANNOUNCES EXECUTIVE APPOINTMENTS.
MEDIA SEMINAR: MEDICINES IN DEVELOPMENT FOR WOMEN
THE NATIONAL PHARMACEUTICAL COUNCIL AND THE WHITE HOUSE OFFICE OF NATIONAL DRUG CONTROL POLICY ANNOUNCE PREVENTION EDUCATION PARTNERSHIP
PATIENTS WITH CHRONIC ILLNESS AT GREATEST RISK IN NEW HEALTH CARE SYSTEM, PHARMACEUTICAL EXECUTIVE SAYS
Wyeth-Ayerst Laboratories Offers Training Program to Help Florida Pharmacists Improve Health Care for Women in their Communities
Takeda Pharmaceuticals America, Inc. and Eli Lilly and Company Provide Grant To National Diabetes Education Initiative; Funds Will Expand Educational...
Slatkin to Chair IASC Scientific Seminar.
National Depression Screening Day: An Important Part of Managing the Cost of Depression.
National Institutes of Health Symposium: Securing NIH Funding Support Sponsored by: New Jersey National Institute of Health Coordinating Council;...
National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters